PRODUCTS
Twist cfDNA Pan-cancer Reference Standards
NGS-based liquid biopsy is a rapidly evolving application that requires accurate and precise reference standards. The Twist Pan-cancer Reference Standard is a high-quality, standardized control for use in the research and development of NGS-based liquid biopsy assays. This reference standard is ideal for establishing the analytical limit of detection (LoD) for specific cancer variants and as a control to track the quality of an NGS assay workflow and assess the fidelity of the assay process during research and development of such assays.
Comprehensive Detection of Cancer Variants
458 unique naturally occurring cancer variants
132 clinically relevant variants
Covers 84 different genes involved in cancer
Better Design of Background
DNA
Background DNA derived from human cfDNA samples
DNA size profile and post-sequencing profile mimic native cfDNA
Designed for Precision and Flexibility
Seven individual VAF percentages to choose from
Digital Droplet PCR verification of VAF percentages
Convenient test set of all VAF percentages available
DNA analysis of the Twist cfDNA Pan-Cancer Reference Standard and competitors reference standards show that Twist more closely mimics native cell-free DNA providing a more true to life test result.
Post sequencing library size distribution comparison between Twist and competitors show how similar Twist mimics native cfDNA samples including the jagged leading peaks.
Have a question?
Get a call from your local Decode Science representative to help you find the best fit genomics products for you.
Or give us a call at:
Contact US
Decode Science Pty Ltd
Level 1, 2-12 Allen St,
Wellington 6011
Phone: 0800 DECODE (332633)
support@decodescience.co.nz